Addus HomeCare Co. (NASDAQ:ADUS) Stock Holdings Lifted by Intech Investment Management LLC

Intech Investment Management LLC lifted its position in Addus HomeCare Co. (NASDAQ:ADUS) by 137.1% in the 3rd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 5,008 shares of the company’s stock after acquiring an additional 2,896 shares during the quarter. Intech Investment Management LLC’s holdings in Addus HomeCare were worth $666,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. UMB Bank n.a. raised its position in Addus HomeCare by 64.2% during the second quarter. UMB Bank n.a. now owns 225 shares of the company’s stock valued at $26,000 after buying an additional 88 shares during the period. Quest Partners LLC purchased a new position in Addus HomeCare during the 2nd quarter valued at about $31,000. Innealta Capital LLC acquired a new position in shares of Addus HomeCare in the 2nd quarter valued at about $44,000. Farther Finance Advisors LLC lifted its position in shares of Addus HomeCare by 9,150.0% in the third quarter. Farther Finance Advisors LLC now owns 370 shares of the company’s stock worth $49,000 after purchasing an additional 366 shares in the last quarter. Finally, Sandia Investment Management LP acquired a new stake in shares of Addus HomeCare during the second quarter worth approximately $58,000. Institutional investors and hedge funds own 95.35% of the company’s stock.

Insider Buying and Selling at Addus HomeCare

In other Addus HomeCare news, Director Esteban Lopez sold 500 shares of the stock in a transaction on Tuesday, September 10th. The stock was sold at an average price of $127.50, for a total transaction of $63,750.00. Following the transaction, the director now owns 3,366 shares in the company, valued at $429,165. This trade represents a 12.93 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO R Dirk Allison sold 12,500 shares of the business’s stock in a transaction dated Monday, November 25th. The shares were sold at an average price of $123.16, for a total transaction of $1,539,500.00. Following the completion of the sale, the chief executive officer now directly owns 141,897 shares of the company’s stock, valued at $17,476,034.52. This represents a 8.10 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 13,500 shares of company stock worth $1,668,265 over the last ninety days. Insiders own 4.60% of the company’s stock.

Addus HomeCare Trading Up 1.3 %

Shares of ADUS stock opened at $122.84 on Friday. The firm’s fifty day moving average price is $127.30 and its two-hundred day moving average price is $123.57. Addus HomeCare Co. has a 1 year low of $85.43 and a 1 year high of $136.12. The firm has a market capitalization of $2.23 billion, a P/E ratio of 28.11, a PEG ratio of 2.12 and a beta of 1.04.

Addus HomeCare (NASDAQ:ADUS) last announced its quarterly earnings data on Monday, November 4th. The company reported $1.30 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.28 by $0.02. The company had revenue of $289.80 million for the quarter, compared to analysts’ expectations of $289.42 million. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. The business’s revenue was up 7.1% compared to the same quarter last year. During the same quarter in the prior year, the business posted $1.03 EPS. As a group, equities research analysts forecast that Addus HomeCare Co. will post 4.58 EPS for the current fiscal year.

Analyst Ratings Changes

Several research analysts have weighed in on ADUS shares. Royal Bank of Canada reiterated an “outperform” rating and issued a $136.00 price objective on shares of Addus HomeCare in a research note on Thursday, November 14th. KeyCorp assumed coverage on shares of Addus HomeCare in a research note on Friday, October 11th. They issued an “overweight” rating and a $150.00 price target on the stock. TD Cowen lifted their price objective on Addus HomeCare from $128.00 to $137.00 and gave the company a “buy” rating in a research report on Thursday, August 8th. Stephens upped their target price on Addus HomeCare from $143.00 to $145.00 and gave the stock an “overweight” rating in a research report on Wednesday, November 6th. Finally, Macquarie reiterated an “outperform” rating and set a $139.00 price target on shares of Addus HomeCare in a report on Monday, November 4th. One analyst has rated the stock with a sell rating, eight have issued a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, Addus HomeCare has a consensus rating of “Moderate Buy” and a consensus price target of $131.63.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.